成人の腎臓病患者における高血圧の「コントロール不良」が明らかに(UL research reveals ‘poor control’ of high blood pressure in adults with kidney disease)

ad

2024-08-08 アイルランド・リムリック大学(UL)

アイルランドの研究によると、慢性腎臓病(CKD)患者の多くが高血圧の管理に失敗していることが判明しました。研究では、50歳以上のCKD患者の82%が高血圧でありながら、血圧管理が不十分であることが明らかになりました。高血圧は腎不全や心臓発作のリスクを高めるため、適切な管理が重要ですが、目標とする血圧を達成している患者はわずか半数以下でした。研究は、CKD患者の血圧管理改善の必要性を強調しています。

<関連情報>

慢性腎臓病を有する地域在住高齢者における高血圧の有病率、認知、治療、コントロール:アイルランドの高齢化に関する縦断的研究 Prevalence, awareness, treatment, and control of hypertension in community-dwelling older adults with chronic kidney disease: the Irish longitudinal study on ageing

Leonard D Browne, Mohammed Y Alamin, Hamid H Miri, Robert Hall, Meera Tandan, Donal Sexton, Austin G Stack
Clinical Kidney Journal  Published:27 June 2024
DOI:https://doi.org/10.1093/ckj/sfae184

成人の腎臓病患者における高血圧の「コントロール不良」が明らかに(UL research reveals ‘poor control’ of high blood pressure in adults with kidney disease)

ABSTRACT

Background
Hypertension is highly prevalent in chronic kidney disease (CKD), posing a significant but modifiable risk for adverse clinical outcomes. This study explored the prevalence, awareness, treatment, and control of hypertension in older Irish adults with CKD.

Methods
Data were analysed from participants in Wave 1 of The Irish Longitudinal Study on Ageing (TILDA) who were aged 50 years and older. CKD was defined as eGFR <60 ml/min/1.72 m2, hypertension defined as systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg and/or self-reported use of antihypertensive medication. Participant awareness and treatment of hypertension was based on self-report and SBP/DBP <140/90 mmHg. Multivariable logistic regression examined relationships with awareness, treatment, and control of hypertension expressed as adjusted odds ratios.

Results
Prevalence of hypertension was significantly higher in participants with CKD than without (81.9% vs 59.7%, P < .001). Among hypertensive individuals, 70.1% (95% CI: 65.8–74.1) were aware, 83.5% (95% CI 80.0–86.6) were on treatment, yet blood pressure control <140/90 mmHg and SBP <120 mmHg were achieved in only 49.3% (CI 44.0–54.7%) and 17.9% (CI 14.4–22.1), respectively. In multivariable analysis, advancing age 1.05 (CI 1.01–1.10), obesity 6.23 (CI 2.51–15.5), diabetes 5.78 (CI 1.55–21.5), and cardiovascular disease 9.89 (CI 3.27–29.9) were associated with higher odds of treatment, while cardiovascular disease 2.35 (CI 1.39–3.99) and combination antihypertensive therapy 1.76 (CI 1.03–3.01) were associated with blood pressure control.

Conclusion
The prevalence of hypertension is substantial in older Irish adults with CKD; however, control is poor. Approximately, one-third of participants were unaware of their hypertensive status and approximately one-fifth were untreated.

KEY LEARNING POINTS

  • Prevalence of hypertension among older Irish adults with CKD is high (81.9%).
  • Treatment with multiple antihypertensive medications is common in CKD patients, yet a significant proportion are undertreated.
  • Despite high awareness and treatment rates (70.1% and 83.5%, respectively), blood pressure control is poor (49.3% achieving <140/90 mmHg, 17.9% achieving systolic blood pressure <120 mmHg).

What was known?

  • Hypertension prevalence is high in CKD patients, yet specific data for older Irish adults were lacking.
  • Previous studies indicated suboptimal hypertension management in CKD, necessitating further investigation.
  • Limited awareness, treatment, and control of hypertension in CKD pose significant challenges to patient outcomes.

This study adds:

  • High prevalence and poor control of hypertension in older Irish adults with CKD.
  • Treatment with multiple antihypertensive medications is common in CKD patients, yet a significant proportion remain undertreated.
  • Achievement of recommended blood pressure targets is challenging in CKD, particularly in the elderly.

Potential impact:

  • The findings underscore the need for more robust quality improvement programmes to improve blood pressure control in CKD.
  • The inclusion of hypertension in the new national Structured Chronic Disease Management (CDM) Programme in Ireland should serve to improve the quality of CKD care in these patients.
医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました